Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 19 de 19
Filter
Add more filters










Publication year range
1.
Biofactors ; 50(1): 214-227, 2024.
Article in English | MEDLINE | ID: mdl-37647209

ABSTRACT

Zinc finger protein ZNF322A is an oncogenic transcription factor. Overexpression of ZNF322A activates pro-metastasis, cancer stemness, and neo-angiogenesis-related genes to enhance lung cancer progression. However, the upstream regulator of ZNF322A is not well defined. Dysregulation of microRNAs (miRNAs) can mediate cancer cell growth, migration, and invasion to promote tumorigenesis. Here, we uncover the mechanism of miRNA-mediated transcriptional regulation in ZNF322A-driven oncogenic events. ZNF322A harbors several putative miRNA-binding sites in the 3'-untranslated region (UTR). We validated that miR-326 downregulated ZNF322A-3'-UTR luciferase activity and mRNA expression. Furthermore, miR-326 suppressed the expression of ZNF322A-driven cancer-associated genes such as cyclin D1 and alpha-adducin. Reconstitution experiments by ectopic overexpression of ZNF322A abolished miR-326-suppressed cancer cell proliferation and cell migration capacity. Moreover, miR-326 attenuated ZNF322A-induced tumor growth and lung tumor metastasis in vivo. Clinically, the expression of miR-326 negatively correlated with ZNF322A mRNA expression in surgically resected tissues from 120 non-small cell lung cancer (NSCLC) patients. Multivariate Cox regression analysis demonstrated that NSCLC patients with low miR-326/high ZNF322A profile showed poor overall survival. Our results reveal that the deregulated expression of miR-326 leads to hyperactivation of ZNF322A-driven oncogenic signaling. Targeting the miR-326/ZNF322A axis would provide new therapeutic strategies for lung cancer patients.


Subject(s)
Carcinoma, Non-Small-Cell Lung , Lung Neoplasms , MicroRNAs , Humans , Carcinogenesis/genetics , Carcinoma, Non-Small-Cell Lung/metabolism , Cell Line, Tumor , Cell Movement/genetics , Cell Proliferation/genetics , Down-Regulation/genetics , Gene Expression Regulation, Neoplastic , Lung Neoplasms/metabolism , MicroRNAs/genetics , MicroRNAs/metabolism , RNA, Messenger/genetics
2.
Case Rep Pathol ; 2020: 9068506, 2020.
Article in English | MEDLINE | ID: mdl-32292620

ABSTRACT

Primary thyroid angiosarcoma is a rare malignant tumor and characterized by its prevalence in Alpine regions of Central Europe, close relation to longstanding goiter, and aggressive clinical course with dismal prognosis. We describe the case of an 83-year-old Chinese female who lives in the coastal area of Taiwan. She came to our hospital due to a progressively enlarged mass at her anterior neck. The sonography of the thyroid revealed a well-circumscribed mass in the left lobe. She underwent left hemithyroidectomy. The diagnosis of angiosarcoma of the thyroid was made and further confirmed at a different institution. To the best of our knowledge, this is the first case of primary thyroid angiosarcoma reported from Taiwan and the sixth Asian afflicted with primary thyroid angiosarcomas in the English literatures. The literature search in the PubMed database identified 58 cases who had histologically proven primary thyroid angiosarcomas. A preliminary analysis of epidemiological presentation, clinical features, immunohistochemical characters, and prognosis of primary thyroid angiosarcoma was proposed. The prognosis of this rare neoplasm is surprisingly favorable in comparison with that of its morphological similar, the anaplastic thyroid carcinoma. The use of a comprehensive panel of immunohistochemical stains, including at least two endothelial markers (especially CD31 and ERG) and PAX-8, in combination with thorough light microscopic examination may assist in the discrimination between these two tumors.

4.
Int J Mol Sci ; 20(1)2019 Jan 03.
Article in English | MEDLINE | ID: mdl-30609861

ABSTRACT

Chloramphenicol is an inexpensive and excellent bactericidal antibiotic. It is used to combat anaerobic infections in the Third World countries, whereas its systemic application has been abandoned in developed countries. However, in recent years, clinicians have reintroduced chloramphenicol in clinical practice. In this study, chloramphenicol was found to repress the oxygen-labile transcription factor, hypoxia inducible factor-1 alpha (HIF-1α), in hypoxic A549 and H1299 cells. Furthermore, it suppressed the mRNA levels of vascular endothelial growth factor (VEGF) and glucose transporter 1, eventually decreasing VEGF release. Chloramphenicol initiated the autophagy pathway in treated cells, as observed by the increase in formation of Atg12-Atg5 conjugates, and in beclin-1 and LC3-II levels. The chloramphenicol-mediated HIF-1α degradation was completely reverted by autophagic flux blockage. In HIF-1α-overexpressing cells, the formation of HIF-1α/SENP-1 (Sentrin/SUMO-specific protease 1) protein complex seemed to facilitate the escape of HIF-1α from degradation. Chloramphenicol inhibited HIF-1α/SENP-1 protein interaction, thereby destabilizing HIF-1α protein. The enhancement in HIF-1α degradation due to chloramphenicol was evident during the incubation of the antibiotic before hypoxia and after HIF-1α accumulation. Since HIF-1α plays multiple roles in infections, inflammation, and cancer cell stemness, our findings suggest a potential clinical value of chloramphenicol in the treatment of these conditions.


Subject(s)
Autophagy/drug effects , Chloramphenicol/pharmacology , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , A549 Cells , Beclin-1/metabolism , Carcinoma, Non-Small-Cell Lung/metabolism , Carcinoma, Non-Small-Cell Lung/pathology , Cell Hypoxia , Cell Line, Tumor , Cell Survival/drug effects , Cysteine Endopeptidases/metabolism , Glucose Transporter Type 1/metabolism , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Lung Neoplasms/metabolism , Lung Neoplasms/pathology , Microtubule-Associated Proteins/metabolism , Protein Binding , Sequestosome-1 Protein/metabolism , Vascular Endothelial Growth Factor A/metabolism
5.
Int J Mol Sci ; 20(2)2019 Jan 10.
Article in English | MEDLINE | ID: mdl-30634582

ABSTRACT

Gastrointestinal mucositis is a serious side effect of chemotherapy. Currently, no effective treatment exists for chemotherapy-induced mucositis, prompting the need to develop an anti-mucositis agent for use in clinics. The present study investigated whether azatyrosine-PBHA (AzP), a histone deacetylase inhibitor, has a therapeutic effect on intestinal mucosa. The results indicated that AzP did not affect the proliferation and viability of cancer cells, outcomes that are achieved by suberoylanilide hydroxamic acid (SAHA). However, AzP could decrease production of the inflammatory mediators interleukin-6 (IL-6), monocyte chemoattractant protein-1 (MCP-1), and tumor-necrosis factor-α (TNF-α). In vivo histopathological assessment showed that AzP reduced cisplatin-induced injury to the jejunum villi and triggered weight loss in the C57BL/6 mice. Immunohistochemistry (IHC) results demonstrated that mice treated with AzP also recovered from cisplatin-induced injury to the intestinal mucosa. Mechanistic in vitro study using DAVID/KEGG enrichment analysis of microarray data and confirmation by a Western blot indicated the influence of AzP on the MEK/ERK and AKT-dependent pathway. In conclusion, the study demonstrated that AzP might regulate the MEK/ERK MAPK signaling pathway to attenuate MCP-1, TNF-α, and IL-6 production and provide opportunities for the development of new anti-inflammatory drugs targeting mucositis.


Subject(s)
Alanine/analogs & derivatives , Antineoplastic Agents/adverse effects , Histone Deacetylase Inhibitors/pharmacology , Hydroxamic Acids , Mucositis/etiology , Mucositis/pathology , Alanine/chemistry , Animals , Anti-Inflammatory Agents/chemistry , Anti-Inflammatory Agents/pharmacology , Disease Models, Animal , Gene Expression Regulation/drug effects , Histone Deacetylase Inhibitors/chemistry , Hydroxamic Acids/chemistry , Inhibitory Concentration 50 , Male , Mice , Molecular Structure , Mucositis/drug therapy , Rats
6.
Toxicol Sci ; 157(1): 196-210, 2017 05 01.
Article in English | MEDLINE | ID: mdl-28184904

ABSTRACT

Blue light-induced phototoxicity plays an important role in retinal degeneration and might cause damage as a consequence of smartphone dependency. Here, we investigated the effects of periodic exposure to blue light-emitting diode in a cell model and a rat retinal damage model. Retinal pigment epithelium (RPE) cells were subjected to blue light in vitro and the effects of blue light on activation of key apoptotic pathways were examined by measuring the levels of Bcl-2, Bax, Fas ligand (FasL), Fas-associated protein with death domain (FADD), and caspase-3 protein. Blue light treatment of RPE cells increased Bax, cleaved caspase-3, FasL, and FADD expression, inhibited Bcl-2 and Bcl-xL accumulation, and inhibited Bcl-2/Bax association. A rat model of retinal damage was developed with or without continuous or periodic exposure to blue light for 28 days. In this rat model of retinal damage, periodic blue light exposure caused fundus damage, decreased total retinal thickness, caused atrophy of photoreceptors, and injured neuron transduction in the retina.


Subject(s)
Apoptosis/radiation effects , Light , Retina/radiation effects , Smartphone , bcl-2-Associated X Protein/metabolism , Animals , Cells, Cultured , Protein Binding , Rats
7.
Sci Rep ; 7: 41927, 2017 02 14.
Article in English | MEDLINE | ID: mdl-28195146

ABSTRACT

The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that is highly expressed in multiple organs and tissues. Whereas AhR mediates the metabolism of xenobiotic and endogenous compounds, its novel function in cancer epithelial-mesenchymal transition (EMT) remains controversial. Autophagy also participates in tumour progression through its functions in cell homeostasis and facilitates adaptation to EMT progression. In the present study, we found that AhR-regulated autophagy positively modulates EMT in non-small cell lung cancer cells. The motility of A549, H1299, and CL1-5 cells were correlated with different AhR expression levels. Invasive potential and cell morphology also changed when AhR protein expression was altered. Moreover, AhR levels exerted a contrasting effect on autophagy potential. Autophagy was higher in CL1-5 and H1299 cells with lower AhR levels than in A549 cells. Both AhR overexpression and autophagy inhibition decreased CL1-5 metastasis in vivo. Furthermore, AhR promoted BNIP3 ubiquitination for proteasomal degradation. AhR silencing in A549 cells also reduced BNIP3 ubiquitination. Taken together, these results provide a novel insight into the cross-linking between AhR and autophagy, we addressed the mechanistic BNIP3 modulation by endogenous AhR, which affect cancer cell EMT progression.


Subject(s)
Autophagy , Carcinoma, Non-Small-Cell Lung/metabolism , Epithelial-Mesenchymal Transition , Lung Neoplasms/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Animals , Carcinoma, Non-Small-Cell Lung/pathology , Cell Line, Tumor , Cell Movement , Humans , Lung Neoplasms/pathology , Membrane Proteins/metabolism , Mice , Mice, Inbred ICR , Mitochondrial Proteins/metabolism , Receptors, Aryl Hydrocarbon/genetics , Ubiquitination
8.
Lab Chip ; 16(8): 1447-56, 2016 Apr 21.
Article in English | MEDLINE | ID: mdl-26987542

ABSTRACT

The extraction of a cell's nucleus is an essential technique required for a number of procedures, such as disease diagnosis, genetic replication, and animal cloning. However, existing nucleus extraction techniques are relatively inefficient and labor-intensive. Therefore, this study presents an innovative, microfluidics-based approach featuring optically-induced cell lysis (OICL) for nucleus extraction and collection in an automatic format. In comparison to previous micro-devices designed for nucleus extraction, the new OICL device designed herein is superior in terms of flexibility, selectivity, and efficiency. To facilitate this OICL module for continuous nucleus extraction, we further integrated an optically-induced dielectrophoresis (ODEP) module with the OICL device within the microfluidic chip. This on-chip integration circumvents the need for highly trained personnel and expensive, cumbersome equipment. Specifically, this microfluidic system automates four steps by 1) automatically focusing and transporting cells, 2) releasing the nuclei on the OICL module, 3) isolating the nuclei on the ODEP module, and 4) collecting the nuclei in the outlet chamber. The efficiency of cell membrane lysis and the ODEP nucleus separation was measured to be 78.04 ± 5.70% and 80.90 ± 5.98%, respectively, leading to an overall nucleus extraction efficiency of 58.21 ± 2.21%. These results demonstrate that this microfluidics-based system can successfully perform nucleus extraction, and the integrated platform is therefore promising in cell fusion technology with the goal of achieving genetic replication, or even animal cloning, in the near future.


Subject(s)
Cell Nucleus , Lab-On-A-Chip Devices , Optical Phenomena , Cell Death , Cell Membrane/metabolism , Electricity , Equipment Design , HEK293 Cells , Humans
9.
Toxicol Sci ; 148(2): 517-30, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26350169

ABSTRACT

High endogenous levels of aryl hydrocarbon receptor (AhR) contribute to hypoxia signaling pathway inhibition following exposure to the potent AhR ligand benzo[a]pyrene (B[a]P) and could alter cellular homeostasis and disease condition. Increasing evidence indicates that AhR might compete with AhR nuclear translocator (ARNT) for complex formation with hypoxia-inducible factor-1α (HIF-1α) for transactivation, which could alter several physiological variables. Nuclear receptor coactivator 2 (NcoA2) is a transcription coactivator that regulates transcription factor activation and inhibition of basic helix-loop-helix Per (Period)-ARNT-SIM (single-minded) (bHLH-PAS) family proteins, such as HIF-1α, ARNT, and AhR, through protein-protein interactions. In this study, we demonstrated that both hypoxia and hypoxia-mimic conditions decreased NcoA2 protein expression in HEK293T cells. Hypoxia response element (HRE) and xenobiotic-responsive element (XRE) transactivation also were downregulated with NcoA2 knockdown under hypoxic conditions. In addition, B[a]P significantly decreased NcoA2 protein expression be accompanied with AhR degradation. We next evaluated whether the absence of AhR could affect NcoA2 protein function under hypoxia-mimetic conditions. NcoA2 and HIF-1α nuclear localization decreased in both B[a]P-pretreated and AhR-knockdown HepG2 cells under hypoxia-mimic conditions. Interestingly, NcoA2 overexpression downregulated HRE transactivation by competing with HIF-1α and AhR to form protein complexes with ARNT. Both NcoA2 knockdown and overexpression inhibited endothelial cell tube formation in vitro. We also demonstrated using the in vivo plug assay that NcoA2-regulated vascularization decreased in mice. Taken together, these results revealed a biphasic role of NcoA2 between AhR and hypoxic conditions, thus providing a novel mechanism underlying the cross talk between AhR and hypoxia that affects disease development and progression.


Subject(s)
Basic Helix-Loop-Helix Transcription Factors/metabolism , Cell Nucleus/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Nuclear Receptor Coactivator 2/metabolism , Receptors, Aryl Hydrocarbon/metabolism , Animals , Aryl Hydrocarbon Receptor Nuclear Translocator/metabolism , Basic Helix-Loop-Helix Transcription Factors/genetics , Cell Hypoxia , Cell Nucleus/drug effects , Cobalt/pharmacology , Dose-Response Relationship, Drug , Gene Expression Regulation , HEK293 Cells , Hep G2 Cells , Heterografts , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Male , Mice, Inbred ICR , Neovascularization, Physiologic , Nuclear Receptor Coactivator 2/genetics , Oxygen/metabolism , Protein Binding , RNA Interference , Receptors, Aryl Hydrocarbon/genetics , Signal Transduction , Transcription, Genetic , Transcriptional Activation , Transfection
10.
Toxicol Sci ; 147(2): 317-25, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26141393

ABSTRACT

To determine the toxic effects of long-term topical usage of fluorometholone (FLM) on ganglion cells using a direct in vivo retinopathological Brown Norway (BN) rat model. The BN rat retinal model was investigated with a minimum of 3 rats and a maximum of 4 rats per group. Rats received vehicle and 0.02% FLM suspension via topical administration 3 times a day for 28 days. The fundus images and retinal vessels were detected on days 1, 14, and 28 using Micron III retinal imaging microscope and fundus fluorescein angiography (FFA). For retinal structures, spectral-domain optical coherence tomography (SD-OCT) images were taken after FFA on days 1, 14, and 28 using an SD-OCT Imaging System. For retinal function, electrical signal transduction of photoreceptors and bipolar cells was determined by electroretinographic (ERG) recording on days 1 and 28 and IOP detection. At the end of the experiment on day 28, immunohistochemistry and TUNEL assay were performed to investigate apoptosis in ganglion cells. Total retina and nerve fiber layer (NFL) to the inner plexiform layer (IPL) were significantly thinner following 28 days of FLM treatment. Hematoxylin and eosin stain showed that there were NFL and ganglion cell layer deformations in the FLM group. With FLM treatment, TUNEL assay showed approximately a 4.68-fold increase in apoptotic cells. Moreover, FLM decreased ERG b-wave amplitude by about 56%. Using ophthalmofundoscopy devices, after 28 days of topical administration, FLM decreased NFL-IPL and total retina thickness. This suggests that long-term FLM induces adverse effects with respect to ganglion cell apoptosis.


Subject(s)
Fluorometholone/adverse effects , Glucocorticoids/adverse effects , Retinal Ganglion Cells/drug effects , Administration, Ophthalmic , Animals , Apoptosis/drug effects , Electroretinography , Fluorometholone/administration & dosage , Fundus Oculi , Glucocorticoids/administration & dosage , In Situ Nick-End Labeling , Ophthalmic Solutions , Rats , Rats, Inbred BN , Retinal Ganglion Cells/pathology , Tomography, Optical Coherence
11.
Accid Anal Prev ; 74: 107-17, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25463950

ABSTRACT

Exploring the continual process of drivers allocating their attention under varying conditions could be vital for preventing motor vehicle crashes. This study aims to model visual behaviors and to estimate the effects of various contributing factors on driver's vision transitions. A visual attention allocation framework, based on certain contributing attributes related to driving tasks and environmental conditions, has been developed. The associated logit type models for determining driver choices for focal points were successfully formulated and estimated by using naturalistic glance data from the 100-car event database. The results offer insights into driver visual behavior and patterns of visual attention allocation. The three focal points that drivers most frequently rely on and glance at are the forward, left and rear view mirror. The sample drivers were less likely to demonstrate troublesome transition patterns, particularly in mentally demanding situations. Additionally, instead of shifting vision directly between two non-forward focal points, the sample drivers frequently had an intermediate forward glance. Thus, seemingly unrelated paths could be grouped into explanatory patterns of driver attention allocation. Finally, in addition to the vision-transition patterns, the potential pitfalls of such patterns and possible countermeasures to improving safety are illustrated, focusing on situations when drivers are distracted, traveling at high speeds and approaching intersections.


Subject(s)
Attention/physiology , Automobile Driving/psychology , Choice Behavior/physiology , Vision, Ocular/physiology , Accidents, Traffic/prevention & control , Environment , Humans , Logistic Models , Safety
12.
Arch Toxicol ; 88(3): 659-71, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24292262

ABSTRACT

Hypoxia-mediated stress responses are important in tumor progression, especially when tumor growth causes the tumor to become deprived of its blood supply. The oxygen-labile transcription factor hypoxia-inducible factor-1 alpha (HIF-1α) plays a critical role in regulating hypoxia stress-related gene expression and is considered a novel therapeutic target. Lung adenocarcinoma cell lines were exposed to minocycline, followed by incubation at hypoxic condition for 3-6 h. Here, we show that minocycline, a second-generation tetracycline, can induce HIF-1α proteasomal degradation under hypoxia by increasing the expression prolyl hydroxylase-2 and HIF-1α/von Hippel-Lindau protein interaction, thereby overcoming hypoxia-induced HIF-1α stabilization. Neither repression of hypoxia-induced phosphatidylinositol-3 kinase/Akt/mammalian target of rapamycin pathway nor inhibition of Hsp90 was required for minocycline-induced HIF-1α degradation. The HIF-1α degradation-enhancing effect of minocycline was evident in both cancerous and primary cells. Minocycline-pretreated, hypoxia-conditioned cells showed a clear reduction in hypoxia response element reporter expression and amelioration of vascular endothelial growth factor C/D (VEGF-C/D), matrix metalloproteinase 2, and glucose transporter 1 expression. By decreasing VEGF secretion of cancerous cells, minocycline could suppress endothelial cell neovasculogenesis. These findings suggest a novel application of minocycline in the treatment of tumor angiogenesis as well as hypoxia-related diseases.


Subject(s)
Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Minocycline/pharmacology , Neovascularization, Pathologic/drug therapy , Prolyl Hydroxylases/metabolism , Von Hippel-Lindau Tumor Suppressor Protein/metabolism , Cell Hypoxia/drug effects , Cell Line/drug effects , Cell Movement/drug effects , Glucose Transporter Type 1/genetics , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Matrix Metalloproteinase 2/genetics , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , Signal Transduction/drug effects , Vascular Endothelial Growth Factor C/genetics , Vascular Endothelial Growth Factor C/metabolism
13.
Accid Anal Prev ; 58: 140-7, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23743253

ABSTRACT

The key to safe driving is the adequate distribution of the driver's attention to the forward area and to other non-forward focal points. However, thus far, current methods are not able to well quantify the entire process of a driver's attention allocation. Therefore, this study proposed a novel concept of renewal cycles for representing and analyzing driver attention allocation. Using the 100-car naturalistic glance data, this study found that 90.74% of drivers' attention allocations were 2-glance renewal cycles. The findings suggest that the sample drivers usually separated their lapses of attention from the forward direction into several sequences by directing their vision back to the forward direction after each visual shift away from it. In addition, although a markedly smaller number of cycles were more than 3-glances (2.09% renewal cycles), drivers were certainly less aware of the frontal area and at a higher risk of having an accident during such cycles. This finding might have striking implications for accident prevention. This area of study deserves further attention. Among the generated renewal cycles, lots of them repeated frequently, especially cycles related to invehicle distractions. To analyze the different characteristics among various attributes, distribution of the common renewal cycles under different conditions was examined. As expected, drivers displayed different renewal cycles under various road conditions and with various driver intentions. Although these sample drivers were not representative, the preliminary research results were promising and fruitful for potential applications, particularly educating novice drivers.


Subject(s)
Attention , Automobile Driving/psychology , Fixation, Ocular , Accidents, Traffic , Eye Movements , Humans
15.
J Agric Food Chem ; 60(37): 9405-14, 2012 Sep 19.
Article in English | MEDLINE | ID: mdl-22920671

ABSTRACT

This study aimed to determine whether brazilin exhibits anti-inflammatory effects that inhibit T helper cell type II (T(H)2) responses and whether it suppresses allergic inflammation reactions in a murine model of asthma. We found that brazilin inhibited the mRNA and protein expression of interleukin (IL)-4 and IL-5 induced by phorbol myristate acetate (PMA) and cAMP in EL-4 T cells in a dose-dependent manner. Following the intratracheal instillation of brazilin in ovalbumin (OVA)-immunized mice, we found that brazilin-treated mice exhibited decreases in the release of IL-4, IL-5, IL-13, eotaxin-1, and tumor necrosis factor-α in bronchoalveolar lavage fluid (BALF); inhibited T(H)2 functioning via a decrease in IL-4 production; and exhibited attenuation of OVA-induced lung eosinophilia, airway hyperresponsiveness, and airway remodeling. These results suggest that brazilin exhibits anti-T(H)2 effects both in vitro and in vivo and may possess therapeutic potential for allergic diseases.


Subject(s)
Anti-Asthmatic Agents/therapeutic use , Asthma/drug therapy , Asthma/immunology , Benzopyrans/therapeutic use , Th2 Cells/immunology , Animals , Anti-Asthmatic Agents/pharmacology , Benzopyrans/pharmacology , Bronchoalveolar Lavage Fluid/immunology , Chemokine CCL11/analysis , Disease Models, Animal , Female , Interleukin-13/analysis , Interleukin-4/analysis , Interleukin-4/antagonists & inhibitors , Interleukin-4/genetics , Interleukin-5/analysis , Interleukin-5/antagonists & inhibitors , Interleukin-5/genetics , Mice , Mice, Inbred BALB C , Ovalbumin/immunology , Th2 Cells/drug effects , Tumor Necrosis Factor-alpha/analysis
16.
Toxicol In Vitro ; 26(4): 552-60, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22313677

ABSTRACT

Epidemiological studies have shown that there is a strong correlation between atherosclerosis and ambient air pollution. In this study, we found that motorcycle exhaust particles (MEP) induced adhesion between cells of the human monocytic leukemia cell line (THP-1) and human umbilical vein endothelial cells (HUVECs) in a time-and dose-dependent manner. In addition, MEP treatment induced both mRNA and protein expression of vascular cell adhesion molecule-1 (VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) in HUVECs. The IκB degradation and p65 nuclear translocation was found in MEP-treated HUVECs, suggested the involvement of nuclear factor-κB (NF-κB). MEP-induced VCAM-1 and ICAM-1 protein expression was inhibited by NF-κB inhibitor BAY 11-7085. Oxidative stress was also involved in the signaling of VCAM-1 and ICAM-1 expression. MEP treatment caused hydrogen peroxide and superoxide formation. Pretreatment with α-tocopherol could inhibit MEP-induced reactive oxygen intermediates generation and suppressed MEP-induced IκB degradation and adhesion molecules expression. Furthermore, the carbon black (CB) nanoparticles with different diameters could induce VCAM-1 and ICAM-1 protein expression; however, polycyclic aromatic hydrocarbons (PAHs) only increased the expression of ICAM-1 but not that of VCAM-1 in HUVECs. In this study, we found that MEPs could induce ICAM-1 and VCAM-1 expression through oxidative stress and NF-κB activation in HUVECs.


Subject(s)
Air Pollutants/toxicity , Intercellular Adhesion Molecule-1/biosynthesis , Motorcycles , Vascular Cell Adhesion Molecule-1/biosynthesis , Vehicle Emissions/toxicity , Cell Adhesion/drug effects , Cell Line, Tumor , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Humans , Intercellular Adhesion Molecule-1/genetics , NF-kappa B/metabolism , Oxidative Stress , Polycyclic Aromatic Hydrocarbons/toxicity , RNA, Messenger/biosynthesis , Soot/toxicity , Up-Regulation , Vascular Cell Adhesion Molecule-1/genetics
17.
Nanotoxicology ; 6(7): 746-56, 2012 Nov.
Article in English | MEDLINE | ID: mdl-21950449

ABSTRACT

Abstract Understanding tissue biodistribution and clearance of zinc oxide nanoparticles (ZnO-NPs) is necessary for its risk assessment. Both fed and intraperitoneally injected ZnO-NPs (2.5 g/kg) were absorbed into circulation (within 30 min post-dosing), then biodistributed to the liver, spleen, and kidney. Intraperitoneally injected ZnO-NPs remained in serum for 72 h and could more effectively spread to the heart, lung, and testes, whereas the clearance for fed ZnO-NPs in serum began 6 h after oral administration. Compared with zinc oxide microparticles (ZnO-MPs), ZnO-NPs exhibited much higher absorptivity and tissue biodistribution in fed treatment. A greater fraction of fed ZnO-NPs localised in the liver resulted in transient histopathological lesions. However, superoxide generation and cytotoxicity were showed in vitro treatment with ZnO-NPs (above 20 µg/mL). Considering both in vitro and in vivo data, the ZnO-NPs induced acute liver toxicity which was in compliance with its absorption, biodistribution, and clearance.


Subject(s)
Nanoparticles/toxicity , Zinc Oxide/pharmacokinetics , Zinc Oxide/toxicity , Absorption , Administration, Oral , Analysis of Variance , Animals , Cell Survival/drug effects , Female , Human Umbilical Vein Endothelial Cells/cytology , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Hydrogen-Ion Concentration , Injections, Intraperitoneal , Kidney/chemistry , Kidney/metabolism , Liver/chemistry , Liver/metabolism , Male , Mice , Mice, Inbred ICR , Micronucleus Tests , Nanoparticles/administration & dosage , Particle Size , Solubility , Spleen/chemistry , Spleen/metabolism , Superoxides/metabolism , Tissue Distribution , Toxicity Tests, Acute , Zinc Oxide/administration & dosage
18.
Toxicol Sci ; 126(1): 162-72, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22166487

ABSTRACT

The explosive development of nanotechnology has caused an increase in unintended biohazards in humans and in the ecosystem. Similar to particulate matter, nanoparticles (NPs) are strongly correlated with the increase in incidences of cardiovascular diseases, yet the mechanisms behind this correlation remain unclear. Within the testing concentrations of 0.1-10 µg/ml, which did not cause a marked drop in cell viability, zinc oxide NPs (ZnO-NPs) induced intercellular adhesion molecule-1 (ICAM-1) messenger RNA, and protein expression in both concentration- and time-dependent manner in treated human umbilical vein endothelial cells (HUVECs). ZnO-NPs treatment cause the activation of Ras-related C3 botulinum toxin substrate 1 (Rac1)/cell division control protein 42 homolog (Cdc42) and protein accumulation of mixed lineage kinase 3 (MLK3), followed by c-Jun N-terminal kinase (JNK) and transcription factor c-Jun activation. Induction of ICAM-1 and phosphorylation of JNK and c-Jun could be inhibited by either JNK inhibitor SP600125 or Rac guanosine triphosphatase inhibitor NSC23766 pretreatment. In addition, pretreatment with NSC23766 significantly reduced MLK3 accumulation, suggesting the involvement of Rac1/Cdc42-MLK3-JNK-c-Jun signaling in the regulation of ZnO-NPs-induced ICAM-1 expression, whereas these signaling factors were not activated in zinc oxide microparticles (ZnO-MPs)-treated HUVECs. The increase of ICAM-1 expression on ZnO-NPs-treated HUVECs enables leukocytes to adhere and has been identified as an indicator of vascular inflammation. Our data are essential for safety evaluation of the clinical usage of ZnO-NPs in daily supplements, cosmetics, and biomedicines.


Subject(s)
Endothelial Cells/drug effects , Intercellular Adhesion Molecule-1/metabolism , MAP Kinase Kinase Kinases/metabolism , Metal Nanoparticles/adverse effects , Zinc Oxide/adverse effects , cdc42 GTP-Binding Protein/metabolism , rac1 GTP-Binding Protein/metabolism , Animals , Aorta, Thoracic/cytology , Aorta, Thoracic/drug effects , Cell Survival/drug effects , Cells, Cultured , Dose-Response Relationship, Drug , Endocytosis , Endothelial Cells/metabolism , Endothelial Cells/ultrastructure , Enzyme Inhibitors/pharmacology , Gene Expression Regulation, Enzymologic/drug effects , Human Umbilical Vein Endothelial Cells/drug effects , Human Umbilical Vein Endothelial Cells/metabolism , Human Umbilical Vein Endothelial Cells/ultrastructure , Humans , Intercellular Adhesion Molecule-1/genetics , MAP Kinase Signaling System/drug effects , Metal Nanoparticles/chemistry , Metal Nanoparticles/ultrastructure , Mice , Mice, Transgenic , Particle Size , RNA, Messenger/metabolism , Zinc Oxide/chemistry , Zinc Oxide/pharmacology , cdc42 GTP-Binding Protein/antagonists & inhibitors , rac1 GTP-Binding Protein/antagonists & inhibitors , Mitogen-Activated Protein Kinase Kinase Kinase 11
19.
Accid Anal Prev ; 42(1): 275-81, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19887168

ABSTRACT

Young motorcyclists have traditionally been considered a high-risk population. Given the critical influence of riders' behaviors on traffic safety, identifying what riders think can help clarify the nature of accidents. Although psychological studies have explored the relationships among personality traits, attitudes and risky driving behavior, the primary difference this study makes from past studies is incorporating both positive and negative effects in a refined causal framework. This study adopts structural equation modeling to analyze data collected from 683 young motorcyclists aged between 18 and 28. The results conclude three primary personality traits of young motorcyclists, namely sensation seeking, amiability and impatience. While amiable riders represent a group of relatively mature and safe riders, the sensation-seeking riders are extremely self-confident, comfortable with unsafe riding and interested in the utility gained from it. Meanwhile, the sensation-seeking ones also are highly aware of traffic conditions, which may lower the chances of getting into an accident, but the accident could be extremely severe if it ever occurs. Impatient riders, having low riding confidence and traffic awareness deficiency, also seek utility from certain risky riding behaviors. However, their fear of an accident leads them to fail to observe surrounding traffic conditions. The result indicates various mental compromise mechanisms for young motorcyclists in conducting riding behaviors. Thus, corresponding countermeasures, including licensure system and ITS roadway development, should consider the heterogeneous characteristics of young riders.


Subject(s)
Motorcycles , Personality , Risk-Taking , Adolescent , Adult , Anger , Factor Analysis, Statistical , Humans , Motorcycles/statistics & numerical data , Temperament , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...